Target intelligence / Profile preview

Claudin-24 (CLDN24)

Target
CLDN24
Molecular classification
Tight junction protein, Membrane protein, Claudin family (CLDN), Four-pass transmembrane protein
01

Overview

Claudin-24 is a polymer-forming membrane protein integral to the structure and function of tight junctions, which act as barriers controlling the flow of water, ions, and solutes between epithelial and endothelial cells[1][2]. Claudins possess four transmembrane domains, two extracellular loops involved in forming paracellular pores and defining charge selectivity, and a cytoplasmic tail interacting with scaffolding proteins (e.g., ZO-1, ZO-2)[2]. Although the claudin family contains 24 members with important physiological and disease roles, most drug development and functional studies focus on other isoforms, such as claudin-4 or -18, not claudin-24[3]. Genomic analyses have mapped CLDN24 among gene clusters containing tumor suppressors, but there are no therapeutically validated functions or drugs specific to this protein[1][3]. No evidence supports CLDN24 as a clinically actionable/therapeutic target or biomarker in current literature. Its alternative naming as claudin-21 is not generally accepted[1], and data for CLDN24 and CLDN21 should not be conflated.

Other names
Claudin-24CLDN24claudin-24Putative claudin-24
02

Biological functions

Paracellular barrier formationRegulation of cell polarityModulation of ion selectivity and charge permeabilitySignal transduction at cell-cell interfaces
03

Disease associations

Cancer

Beyond the preview

Go deeper on Claudin-24 (CLDN24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claudin-24 (CLDN24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call